Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 April 2024 | Story VALENTINO NDABA | Photo SUPPLIED
UFS Graduation April 2024
The University of the Free State celebrated autumn graduation season from 12-20 April 2024.

As the autumn season unfolded, the University of the Free State (UFS) eagerly anticipated the commencement of its graduation ceremonies, a time to celebrate the academic achievements of its esteemed students. The ceremonies, scheduled from 12-20 April 2024, honoured the accomplishments of the graduating class of 2023, across the Qwaqwa and Bloemfontein campuses.

Undergraduate and postgraduate achievements

The graduating class represented a diverse array of disciplines, showcasing the university’s commitment to fostering excellence across various fields. In total, 5 442 undergraduate qualifications and 2 345 postgraduate qualifications were conferred, reflecting the dedication and perseverance of both students and faculty members.

Honouring distinguished individuals

The graduation ceremonies also recognised the contributions of distinguished individuals who have made a significant impact in their respective fields. Among them were Archbishop Thabo Makgoba and Prof Salim Abdool Karim who received honorary degrees from the UFS on 12 and 18 April 2024, respectively.  

Archbishop Makgoba, Archbishop of Cape Town and President of the South African Council of Churches, was recognised for his outstanding contributions to theology, social justice, and education activism. Prof Karim, renowned for his groundbreaking research in AIDS and COVID-19, was honoured for his exceptional work in medical virology. 

Nurturing excellence and social impact

The graduation ceremonies not only symbolised the culmination of academic journeys but also underscored the UFS Vision 130 commitment to academic excellence, societal impact, and the cultivation of future leaders. The university continues to play a pivotal role in shaping the intellectual landscape of South Africa and beyond. 

As the graduating class of 2023 embarks on new endeavours, they carry with them the values instilled by their alma mater, poised to make meaningful contributions to society.


WATCH: April 2024 Graduation Ceremonies.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept